Aimed Alliance has created a new fact sheet dedicated to H.R. 3, otherwise known as the Elijah E. Cummings Lower Drug Costs Now Act, a piece of pending legislation that could be included in the new federal infrastructure bill. The bill includes a variety of provisions aimed at lowering prescription drug prices and patient costs in Medicare and private markets, ranging from price negotiations to out-of-pocket caps. Some of the provisions, including the out-of-pocket cap for Medicare beneficiaries, allowing beneficiaries to spread out cost-sharing throughout the year, and reinvestment in innovation could lead to strong patient outcomes, increasing prescription availability while providing direct relief to patients. However, other provisions could harm patients by leading to higher initial drug prices, decreased incentives to innovate, and the loss of an estimated eight to 15 fewer drugs in the next 10 years. Read more here.